LoadingLoadingLoadingThe quick read
Latest quote·Oct 15
Net selling: insiders sold $1.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $1.4M and bought $0 of FICO stock on the open market in the 90 days to Oct 15, 2026, according to SEC Form 4 filings. $1.4M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Manolis, Eva (Director), who sold $1.4M. The latest filing was on Jul 31, 2026.
None. No member of Congress disclosed a FICO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 15, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position, insiders have been net selling, and 2 fin-fluencers are discussing it.
Buys/Adds (1)
Citadel
$40.7M
added
Sells/Trims (2)
D.E. Shaw
$191.8M
trimmed
D.E. Shaw
$468.3M
trimmed
Sells (1)
Manolis Eva
$1.4M
sold
Sells (1)
No tracked top-trader positions in FICO right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Financial period
Q3
Adjusted EPS
$11.78 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $12.18 / $11.78Yahoo Finance | +3.43% beat | $674.2M / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | $12.50 / $10.97Yahoo Finance | +13.91% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 28, 2026 | $7.33 / $7.08Yahoo Finance | +3.46% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $7.74 / $7.36Yahoo Finance | +5.21% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 30, 2025 | $8.57 / $7.70Alpha Vantage | +11.30% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | $7.81 / $7.44Alpha Vantage | +4.97% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 4, 2025 | $5.79 / $6.08Alpha Vantage | -4.77% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | $6.54 / $6.39Alpha Vantage | +2.35% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 15, 2026
EPS expected
$10.32 to $11.69
Revenue expected
16 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $515.8M | $512.0M | $691.7M | $674.2M |
| Cost of what it sold | $91.2M | $87.3M | $91.2M | $87.0M |
| Gross profit | $424.6M | $424.7M | $600.5M | $587.2M |
| What it spent | ||||
| Research and development | $51.0M | $49.9M | $53.9M | $53.7M |
| Sales and admin | $125.5M | $140.7M | $144.1M | $170.8M |
| Other operating costs | $10.9M | — | — | — |
| Total operating expenses | $187.4M | $190.6M | $198.0M | $224.5M |
| What was left | ||||
| Operating profit | $237.2M | $234.0M | $402.5M | $362.6M |
| Interest on debt | $39.9M | $42.0M | $44.6M | $59.9M |
| Profit before tax | $202.5M | $191.9M | $356.0M | $314.7M |
| Tax | $47.4M | $33.6M | $91.6M | $77.5M |
| Net profit | $155.0M | $158.4M | $264.5M | $237.2M |
| EBITDA | $246.4M | $238.0M | $404.5M | $378.8M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
Should You Sell Your Fair Isaac Stock Now?
Leans bearishOct 13BofA Adjusts Price Target on Equifax to $200 From $210, Keeps Buy Rating
Leans bearishOct 13FCHL Stock Draws Day Traders As Volatility Spikes
NeutralOct 13Wealth, Assets and Custody: What to Watch When Morgan Stanley, BlackRock and State Street Report
BullishOct 13Jefferies Adjusts Price Target on Equifax to $170 From $200
Leans bearishOct 13Verisign EVP Thomas Indelicarto sells $142,190 in company stock
NeutralOct 13Axsome Therapeutics Stock: 12 Straight Red Days, Down 15%
NeutralOct 13Free float of Fair Isaac Corporation – HAN:FRI
NeutralOct 13